News

Search Articles

31 - 38 of 38 Results Clear All

Article June 22, 2015

Gladstone Welcomes Recipient of Donald A. King Summer Research Fellowship

Brianna Bibel, an undergraduate student at St. Mary’s College of California, has joined the lab of Dr. Steve Finkbeiner for the summer after receiving a 2015 Donald A. King Summer Research Fellowship from the Huntington’s Disease Society of America (HDSA).

Huntington’s Disease Finkbeiner Lab

Article June 8, 2015

Scientists Identify New Drug Target to Treat ALS

Revelations about a key cellular pathway have important implications for neurodegenerative diseases like ALS and frontotemporal dementia.

Finkbeiner Lab

Article September 19, 2014

Gladstone Investigator Receives Two NIH Common Fund Grants to Explore Emerging Opportunities

Grants are to be used for innovative and transformative research into the detailed cell biology of the brain.

Finkbeiner Lab

Article January 7, 2014

Two Proteins’ Destructive Dance

Revolutionary imaging technique reveals that a unique protein interaction may be key to driving the most common genetic cause of Parkinson’s disease

Finkbeiner Lab

July 20, 2013

Failure to Destroy Toxic Protein—Not Buildup of Protein Itself—Contributes to Progression of Huntington’s Disease

SAN FRANCISCO, CA—Alzheimer’s, Huntington’s, Parkinson’s. Names forever linked to what they represent: diseases that ravage the brain’s neurons and leave entire regions to wither and die.

Finkbeiner Lab Huntington’s Disease

June 8, 2013

Gladstone Scientists Map Process by which Brain Cells Form Long-Term Memories

SAN FRANCISCO, CA—Scientists at the Gladstone Institutes have deciphered how a protein called Arc regulates the activity of neurons—providing much-needed clues into the brain’s ability to form long-lasting memories.

Finkbeiner Lab

January 6, 2013

Unique Protein Interaction May Drive Most Common Genetic Cause of Parkinson’s Disease

San Francisco, CA—The most devastating aspect of Parkinson’s disease may not be its debilitating symptoms, which rob its victims of their ability to control their own movement. It may not be the millions around the world and their families who suffer each day from the disease’s harmful effects.

Finkbeiner Lab

December 3, 2012

ALS Therapy Development Institute and Gladstone Institutes Collaborate to Discover Potential ALS Treatments

CAMBRIDGE, MA and SAN FRANCISCO, CA—The ALS Therapy Development Institute (ALS TDI) and the Gladstone Institutes today announced the formation of a research collaboration to speed the discovery of potential treatments for ALS through the preclinical drug development process.

ALS Finkbeiner Lab

Are You a Journalist Looking to Write about Gladstone?

Explore Info for Media

Are You a Journalist Looking to Write about Gladstone?

Sign Up for Our Newsletter

Congrats to Jennifer Doudna, winner of the 2020 Nobel Prize in Chemistry!